Literature DB >> 31523635

The Effects of Chlorhexidine Dressing on Health Care-Associated Infection in Hospitalized Patients: A Meta-Analysis.

Hou-Xing Wang1, Shu-Yuan Xie1, Hao Wang1, Hao-Kai Chu1.   

Abstract

BACKGROUND: To assess the effects of chlorhexidine dressing on health care-associated infection in hospitalized patients.
METHODS: We searched for English-language published randomized controlled trials (RCTs) in Cochrane Library, EMBASE and PubMed between January 1998 and January 2018. We used meta-analysis to calculate the risk ratios (RRs) and 95% confidence intervals (CIs) of the data, and using the I 2 assessment to summarize the heterogeneity of RCTs and the funnel plot and Egger regression test to evaluate publication bias.
RESULTS: A total of 13 RCTs were included in our meta-analysis, including 7555 patients and 11,931 catheters. The effects of chlorhexidine dressing on the incidence of catheter-related bloodstream infections (CRBSIs) were reported in 13 RCTs, and the incidence of CRBSIs were 1.3% (80/6160) in the chlorhexidine group and 2.5% (145/5771) in the control group. We used a forest plot to determine the risk ratio (RR) of chlorhexidine dressing on the incidence of CRBSIs, and our results showed that chlorhexidine dressing significantly reduced the incidence of CRBSIs (RR 0.55, 95% CI 0.39-0.77, P<0.001). Moreover, we also analyzed the effects of chlorhexidine dressing on the incidence of catheter colonization and catheter-related infections (CRIs), and our forest plot results showed that chlorhexidine dressing significantly reduced the incidence of catheter colonization (RR 0.52, 95% CI 0.40-0.67, P<0.001) and the incidence of CRIs (RR 0.43, 95% CI 0.28-0.66, P<0.001) in hospitalized patients.
CONCLUSION: The use of chlorhexidine dressings for hospitalized patients significantly reduce the incidence of CRBSIs, catheter colonization and CRIs.

Entities:  

Keywords:  Catheter-related bloodstream infections; Chlorhexidine dressing; Randomized controlled trials

Year:  2019        PMID: 31523635      PMCID: PMC6717407     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


Introduction

Central venous catheters (CVCs) are an important source of bloodstream infections (BSIs) in hospitalized critically ill patients and are closely related to patients’ mortality (1). During the hospitalization, patients complicated with catheter-related bloodstream infections (CRBSIs) and/or catheter-related infection (CRIs) caused their illness to worsen, the length of hospital stay was extended, and hospitalization expenses increased (2–4). According to data reported by the Centers for Disease Control and Prevention in US in 2009, the number of CRBSIs in the Intensive Care Unit (ICU) was 12,000–18,000, and the medical expenses generated per case were about $16,550, and the overall mortality rate was increased by 15%–25% (5). At present, due to the limited number of antimicrobial drugs and the emergence of multi-drug resistance, the task of anti-infection is becoming more and more difficult. The Clinical Laboratory Standards Association has developed a standardized method for testing antimicrobial sensitivity, reliability and repeatability (6). The main mechanism of CRBSIs is the in vivo bloodstream contamination caused by the translocation of microorganisms through the skin of the catheter into the blood vessels (7). Therefore, blocking the pathway by which microorganisms invade the blood from the skin is an important method for reducing CRBSIs. Chlorhexidine has a broad spectrum of antibacterial activity against Gram-positive bacteria, Gram-negative bacteria, aerobic bacteria, anaerobic bacteria and fungi, and the use of chlorhexidine for skin disinfection in ICU patients reduces the spread of microbes and the incidence of CRBSIs (8). In recent years, there has been increasing interest in using chlorhexidine to disinfect skin to reduce acquired infections in hospitalized patients. Chlorhexidine dressings reduce the incidence of CRBSIs (9–13), but some studies have the opposite result, do not support the use of chlorhexidine dressings (14–18). Therefore, in this study, we used a meta-analysis to determine the effects of chlorohexidine dressings on the incidence of CRBSIs, catheter colonization and CRIs in hospitalized patients.

Methods

Search Strategy

Under the guidance of librarians, we searched for published studies between January 1998 and January 2018 in three large databases worldwide, including Cochrane Library, EMBASE and PubMed. The keywords were used in the search include: “Chlorhexidine”, “dressing(s)”, “Catheter-related bloodstream infections”, “Catheter-related Infections”, “Central line-associated bloodstream infections” and “catheter colonization”. Inclusion criteria: 1.) The selected articles were all published in English; 2.) Randomized controlled trials (RCTs) published before January 2018; 3.) Hospitalized patients used chlorhexidine dressings; 4.) Access to detailed clinical data.

Data Abstraction

We developed a standardized form for extracting all the data, and the two judges independently read the full text of the article and extracted the data. If there was a disagreement between the results or data extracted by the two senators, the third senator presided over the negotiation and discussion to resolve the differences. The data used by our study was limited to published results. The data extracted from each study included: authors of the article, time of publication, study population, department, chlorhexidine group and control group, clinical outcomes, related definitions, etc. The primary outcome was the correlation between chlorhexidine dressing and CRBSIs. The secondary outcome was the effects of chlorhexidine dressing on the incidence of catheter colonization and CRIs.

Risk of Bias Assessment

We used the Cochrane bias risk tool to assess the risk of RCTs bias in each article. According to the methods, two authors independently make high, low or unclear material deviation risk judgments for each RCT (19). We used Review Manager 5.2 to assess the risk of bias in the included studies.

Statistical Analysis

One author entered the obtained data into Review Manager 5.2 software, and another author verifies the accuracy of the input data. We used meta-analysis to calculate the risk ratios (RRs) and 95% confidence intervals (CIs) of the data, and using the I2 assessment to summarize the heterogeneity of RCTs. When I2> 50% or P≥0.10, the heterogeneity was considered significant (20), and we used the random-effects model. If the heterogeneity was not significant, we used a fixed-effects model. We used the Egger regression test and the funnel plot to evaluate publication bias (21). A P value <0.05 was considered statistically significant.

Results

Included studies

We searched a total of 1,034 documents in three large databases (Fig. 1.), including 105 from the Cochrane database, 136 from the Embase database, and 793 from the PubMed database. Overall, 660 articles were excluded because these documents did not meet the inclusion criteria, such as 518 articles were related to “chlorhexidine bathing”, 132 articles were “review” or “comment”, 9 articles were animal experiments, and 1 articles could not be searched for full text. The 27 full-text articles were fully reviewed, 11 articles were not RCT, 2 studies were incomplete, and one articles did not obtain the required data. Finally, a total of 13 RCTs were included in our meta-analysis (9–18, 22–24), 13 of which involved the relationship between chlorhexidine dressing and CRBSIs (8 studies in the ICU (9, 10, 12–15, 19–21, 23, 24) and 5 in the non-ICU (11, 16–18, 22)), 7 studies related to the effects of chlorhexidine dressing on catheter colonization (9, 10, 13–15, 23, 24), and 4 articles related to chlorhexidine dressing and CRIs correlation (10, 13, 15, 24).
Fig. 1:

Flowchart for the study selection process

Trial Characteristics

The characteristics of the 13 RCTs were summarized in Table 1, which includes study time, population, department/setting, catheter type, skin disinfection method, chlorhexidine group and control group for each study. Among them, 4 RCTs were for children (9, 13, 18, 23), 2 RCTs were conducted by the same center at different time periods (10, 24), and 1 study did not provide a time interval (14). In addition, the relevant definitions and conclusions involved in each of the studies were summarized in Table 2.
Table 1:

Characteristics of the included studies

StudyPopulationSettingCatheter TypeSkin antisepticInterventionControlDuration
Roberts BL et al. 1998 (14)Adult patients requiring CVC during a 7 week periodICUCVCsChlorhexidine 0.5% in 70% alcoholChlorhexidine impregnated dressingOcclusive dressingNA
Garland JS et al. 2001 (9)Neonates with CVC expected to remain in place a minimum of 48 hoursNeonatal ICUCVCsIntervention group: 70% alcohol scrub, Control group: 10% povidone iodine skin scrubChlorhexidine dressingPolyurethane dressingJune 1994 to August 1997
Chambers ST et al. 2005 (22)Adult patients undergoing chemotherapyHaematology unitCVCsAlcohol povidone iodine 10%Chlorhexidine dressingsNo dressingAugust 1998 to December 2001
Levy I et al. 2005 (23)Pediatric patients requiring CVC for minimum of 48 hoursPediatric cardiac ICUCVCsChlorhexidineChlorhexidine gluconate impregnated sponge dressingPolyurethane dressingJanuary 2002 to March 2003
Ruschulte H et al. 2009 (11)Adults with hematologic or oncologic malignancy with catheter expected for minimum of 5 daysHaematology and oncology unitCVCsAlcohol sprayChlorhexidine gluconate-impregnated wound dressingStandard sterile transparent wound dressingJanuary 2004 to January 2006
Timsit JF et al. 2009 (10)Adult patients requiring catheter minimum of 48 hoursICUCVCs, arterial catheter4% aqueous povidoneiodine scrub solution followed by 5% povidoneiodine in 70% alcohol solutionChlorhexidine gluconate–impregnated sponge dressingStandard dressingDecember 2006 to June 2008
Arvaniti K et al.2012 (15)Adult patients requiring catheter at least 72 hoursICUCVCsNAChlorhexidine gluconate–impregnated sponge dressingStandard dressingJune 2006 to May 2008
Timsit JF et al. 2012 (24)Adult patients expected to require catheter for at least 48 hoursICUCVCsAlcoholpovidone or alcohol chlorhexidineChlohexidine-gel dressingStandard dressingMay 2010 to July 2011
Scheithauer S et al. 2014 (12)NAA medical ICU and a cardiology ICUCVLs0.1% octenidine dihydrochloride and 2% 2-phenoxyethanolChlorhexidine-containing dressingStandard dressingNovember 2010 to may 2012
Düzkaya DS et al. 2016 (13)Pediatric patientsPediatric ICUCVCs10% povidone-iodine2% Chlorhexidine impregnated dressingSterilized padDecember 2012 to January 2014
Biehl LM et al. 2016 (16)Patients undergoing chemotherapy with an expected CVC use of ≥10 daysHematology departmentCVCsAlcohol chlorhexidineChlorhexidine-containing dressingNon-chlorhexidine control dressingsFebruary 2012 to September 2014
Webster J et al. 2017 (17)Hospital inpatients requiring a peripherally inserted central catheterTertiary referral hospitalPICCs2% chlorhexidine gluconate in 70% isopropyl alcoholChlorhexidine gluconate dressingPolyhexamethylene biguanide disc dressingFebruary 2016 to July 2016
Gerçeker GÖ et al. 2017 (18)Pediatric hematology-oncology patientsPediatric hematology unitCVCsChlorhexidine gluconateChlorhexidine dressingAdvanced dressingOctober 2014 to May 2015

CVC(s), central venous catheter(s); CVLs, central venous lines; PICCs, peripherally inserted central catheters; ICU, intensive care unit; NA, not applicable

Table 2:

Outcomes from the included studies

StudyDefinitions of CRBSIsDefinition of catheter colonizationDefinition of CRIsOutcomesConclusion
Roberts BL et al. 1998 (14)Clinical infection with the same organism isolated from catheter tip and bloodIsolation of the same organism from CVCs tip and exit site, and the organism was not from an infectionNAIncidence of CRBSIs, incidence of catheter colonizationNo statistical difference
Garland JS et al. 2001 (9)Clinical infection with same organism isolated from catheter tip and bloodSemi-quantitative catheter colony count >15 cfusNAIncidence of CRBSIs, incidence of catheter colonizationCRBSIs decreased
Chambers ST et al. 2005 (22)Fever and positive blood cultures without alternative infection source, and catheter tip culture with >15 colonies of the same organismNANAIncidence of CRBSIsExit-site/tunnel infections decreased
Levy I et al. 2005 (23)Bacteremia with isolation of the same organism from CVCs tip and blood>15 cfus by the roll-plate technique, without signs of infectionNAIncidence of CRBSIs, incidence of catheter colonizationCatheter colonization decreased
Ruschulte H et al. 2009 (11)Clinical evidence of infection and time-to positivity method used with CVC and peripherally drawing blood culturesNANAIncidence of CRBSIsCRBSIs decreased
Timsit JF et al. 2009 (10)Clinical infection without alternative source and quantitative catheter tip culture isolating the same organismQuantitative CVC tip culture ≥1000 cfus/mLCatheter-related clinical sepsis without bloodstream infection and/or catheter related bloodstream infectionIncidence of CRBSIs, incidence of catheter colonization, incidence of CRIsCRBSIs decreased
Arvaniti K et al.2012 (15)Quantitative CVC tip culture with >1000 cfus/mL with systemic signs of sepsisQuantitative CVC tip culture with >1000 cfus/mL and no systemic signs of sepsisPositive quantitative culture of the tip plus clinical evidence of sepsis without additional sites of infection with the same microorganismIncidence of CRBSIs, incidence of catheter colonization, incidence of CRIsNo statistical difference
Timsit JF et al. 2012 (24)Correlation between peripheral blood culture and quantitative tip culture without other likely sourceQuantitative CVC tip culture >1000 CFU/mL and no systemic signs of sepsisCatheter-related clinical sepsis without bloodstream infection and/or catheter related bloodstream infectionIncidence of CRBSIs, incidence of catheter colonization, incidence of CRIsCRIs decreased
Scheithauer S et al. 2014 (12)NANANAIncidence of CRBSIsCRBSIs decreased
Düzkaya DS et al. 2016 (13)>15 cfus in the catheter-end culture, and microorganisms in the 2 blood samples that have the same antibiotic resistance pattern as the microbes in the catheter end>15 cfus in the catheter-end culture, without signs of infection>15 cfus in the culture of the catheter end and fndings of inflammation at the catheter insertion site without blood-borne infectionIncidence of CRBSIs, incidence of catheter colonization, incidence of CRIsCRBSIs decreased, Catheter colonization decreased
Biehl LM et al. 2016 (16)According to the AGIHO-DGHO guidelines (2)NANAIncidence of CRBSIsNo statistical difference
Webster J et al. 2017 (17)Bacteraemia or fungaemia obtained from a peripheral vein and taken while the PICC was in situ, or within 48 h of removalNANAIncidence of CRBSIsNo statistical difference
Gerçeker GÖ et al. 2017 (18)According to the AGIHO-DGHO guidelines (2)NANAIncidence of CRBSIs,No statistical difference

CVC(s), central venous catheter(s); CRBSIs, catheter-related bloodstream infections; CRIs, catheter-related infections; NA, not applicable; AGIHO-DGHO, the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Flowchart for the study selection process Characteristics of the included studies CVC(s), central venous catheter(s); CVLs, central venous lines; PICCs, peripherally inserted central catheters; ICU, intensive care unit; NA, not applicable Outcomes from the included studies CVC(s), central venous catheter(s); CRBSIs, catheter-related bloodstream infections; CRIs, catheter-related infections; NA, not applicable; AGIHO-DGHO, the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Quality Assessment

We used Cochrane bias to assess selection bias or attribution bias in 13 RCTs. As shown in Figs. 2. and 3, because we did not retrieve the blinded evaluation of the study results, the risk of detection and performance bias in most studies was not clear. Three studies showed a high risk of bias due to lack of participants and personnel blinding (11, 12, 22).
Fig. 2:

Risk of bias graph for the randomized controlled trials

Fig. 3:

Risk of summary for the randomized controlled trials. “+” indicates a low risk of bias, “−” indicates a high risk of bias, and “?” indicates an unclear risk of bias

Risk of bias graph for the randomized controlled trials Risk of summary for the randomized controlled trials. “+” indicates a low risk of bias, “−” indicates a high risk of bias, and “?” indicates an unclear risk of bias

Clinical outcomes

A total of 7555 patients and 11,931 catheters were included in the 13 RCTs (9–18, 22–24), including 6,160 catheters in the chlorhexidine group and 5,771 catheters in the control group. The effects of chlorhexidine dressing on the incidence of CRBSIs were reported in 13 RCTs, and the incidence of CRBSIs was 1.3% (80/6160) in the chlorhexidine group and 2.5% (145/5771) in the control group, of which 5 studies indicated chlorhexidine dressing significantly reduced the incidence of CRBSIs (9–13). We used a forest plot to determine the risk ratio of chlorhexidine dressing on the incidence of CRBSIs, and the results showed that chlorhexidine dressing significantly reduced the incidence of CRBSIs (RR 0.55, 95% CI 0.39–0.77, P<0.001) (Fig. 4.) in hospitalized patients. In addition, we performed a subgroup analysis showing that chlorhexidine dressing significantly reduced the incidence of CRBSIs in both ICU (RR 0.55, 95% CI 0.31–0.97, P=0.04) and non-ICU (RR 0.60, 95% CI 0.40–0.90, P=0.01).
Fig. 4:

Forest plot of chlorhexidine dressing and control groups on the incidence of catheter-related bloodstream infections using a random-effects model. M-H indicates Mantel-Haenszel

Forest plot of chlorhexidine dressing and control groups on the incidence of catheter-related bloodstream infections using a random-effects model. M-H indicates Mantel-Haenszel Seven RCTs reported the relationship between chlorhexidine dressing and the incidence of catheter colonization (9, 10, 13–15, 23, 24), and the incidence of catheter colonization was 5.5% (256/4666) in the chlorhexidine group and 11.8% (531/4514) in the control group. Our forest plot results suggested that chlorhexidine dressing significantly reduced the incidence of catheter colonization (RR 0.52, 95% CI 0.40–0.67, P<0.001) (Fig. 5.) in hospitalized patients. Moreover, four RCTs reported the effects of chlorhexidine dressing on the incidence of CRIs (10, 13, 15, 24), and the incidence of CRIs was 0.7% (29/4261) in the chlorhexidine group and 1.6% (66/4086) in the control group. Our forest plot results showed that chlorhexidine dressing significantly reduced the incidence of CRIs (RR 0.43, 95% CI 0.28–0.66, P<0.001) (Fig. 6.) in hospitalized patients.
Fig. 5:

Forest plot of chlorhexidine dressing and control groups on the incidence of catheter colonization using a random-effects model. M-H indicates Mantel-Haenszel

Fig. 6:

Forest plot of chlorhexidine dressing and control groups on the incidence of catheter-related infections using a fixed-effects model. M-H indicates Mantel-Haenszel

Forest plot of chlorhexidine dressing and control groups on the incidence of catheter colonization using a random-effects model. M-H indicates Mantel-Haenszel Forest plot of chlorhexidine dressing and control groups on the incidence of catheter-related infections using a fixed-effects model. M-H indicates Mantel-Haenszel

Publication bias

We used a funnel plot and Begg’s and Egger’s test to assess included RCTs publication bias, and our results showed that the incidence of CRBSIs, catheter colonization and CRIs were no publication biased (P>0.05) (Fig. 7.).
Fig. 7:

Funnel plots of meta-analysis for the effects of chlorhexidine dressing on catheter-related bloodstream infections (A, Begg’s test, P=0.42; Egger’s test, P=0.67), catheter colonization (B, Begg’s test, P=0.21; Egger’s test, P=0.35), and catheter-related infection (C, Begg’s test, P=0.46; Egger’s test, P=0.90). The results revealed no publication bias, as all P values were >0.05. SE, standard error; RR, risk ratio

Funnel plots of meta-analysis for the effects of chlorhexidine dressing on catheter-related bloodstream infections (A, Begg’s test, P=0.42; Egger’s test, P=0.67), catheter colonization (B, Begg’s test, P=0.21; Egger’s test, P=0.35), and catheter-related infection (C, Begg’s test, P=0.46; Egger’s test, P=0.90). The results revealed no publication bias, as all P values were >0.05. SE, standard error; RR, risk ratio

Discussion

Inpatients often need to establish intravascular catheters to treat critically ill and severe diseases such as cancer chemotherapy, parenteral nutrition, hemodialysis, long-term intravenous antibiotics and organ transplantation, etc. (25, 26). In the United States, more than 5 million inpatients require central venous access each year (27). However, catheter-related bloodstream infections (CRBSIs) is an important factor leading to increased hospital stay, total cost, and increased mortality (28). The occurrence of CRBSIs is usually caused by skin microbes invading the subcutaneous pipeline, and blocking the displacement of microorganisms can effectively prevent medically relevant CRBSIs (29). Skin disinfection with chlorhexidine significantly reduce the incidence of CRBSIs, which is simple, effective and cost-effective (30). A number of studies reported that chlorhexidine dressing can reduce the invasion of extra-catheter microbes and reduce the incidence of CRBSIs (9–13). However, some studies found that the use of chlorhexidine dressing did not have any effect on the incidence of CRBSIs. In our study, we used a meta-analysis to determine the effects of chlorohexidine dressing on the incidence of CRBSIs, catheter colonization and catheter-related infection (CRIs) in hospitalized patients. A total of 13 RCTs were included in our meta-analysis, including 7555 patients and 11,931 catheters. Our results showed that chlorhexidine dressing significantly reduced the incidence of CRBSIs in hospitalized patients. To determine whether chlorhexidine dressings are equally effective in preventing the incidence of CRBSIs in ICU and non-ICU patients, we performed a subgroup analysis. Our results showed that chlorhexidine dressing significantly reduced the incidence of CRBSIs in both ICU and non-ICU. These results indicated that the use of chlorhexidine dressing significantly reduced the invasion of microbes outside the catheter and inhibited the growth of skin microbes (6–8). The six studies included in our meta-analysis first disinfected the skin with chlorhexidine and then covered the catheter inlet with chlorhexidine dressings (14, 16–18, 23, 24), four studies used alcohol for skin disinfection (9–11, 22), and one study did not record the disinfectant used for skin disinfection (15). Moreover, of the 13 RCTs, six RCTs used chlorhexidine-impregnated sponge dressings (10, 11, 13–15, 23), and seven RCTs used the chlorhexidine dressings (9, 12, 16–18, 22, 24), which did not indicate the type. A meta-analysis (31), reported that the use of chlorhexidine impregnated dressings can effectively prevent CRBSIs, including arterial catheters for hemodynamic monitoring. In our meta-analysis, eight studies previously evaluated were included (9–11, 14, 15, 22–24), and four RCTs published in recent years were included (12, 13, 16–18), excluding a study that did not retrieve the full text. We also analyzed the relationship between chlorhexidine dressing and the incidence of catheter colonization. Seven RCTs were included in our analysis (9, 10, 13–15, 23, 24), and the incidence of catheter colonization was 5.5% (256/4666) in the chlorhexidine group and 11.8% (531/4514) in the control group. Our results suggested that the use of chlorhexidine dressing significantly reduced the incidence of catheter colonization in hospitalized patients. Moreover, four RCTs reported the effect of chlorhexidine dressings on the incidence of CRIs (10, 13, 15, 24), and our forest plot results showed that chlorhexidine dressing also significantly reduced the incidence of CRIs in hospitalized patients. Our meta-analysis has four limitations. Firstly, the main research object of most of the studies we have included were central venous catheters (CVCs), but one study was peripherally inserted central catheters (PICCs). Different methods of indwelling CVCs might have an impact on the results of the study. Secondly, we only included full-text journal articles published in English, and non-English languages and conference papers were excluded. Therefore, some RCTs were not included in our analysis, which might lead to publication bias or heterogeneity. Thirdly, the products of chlorhexidine dressing used in the studies were different, and the doses of chlorhexidine contained in the dressings were also different. These factors might have a negative impact on these studies. Fourthly, the effectiveness of chlorhexidine dressings for CRBSI prevention might be inconsistent among different populations, such as neonates, children, adults and seniors. However, our analysis did not separate these populations, so our results might be heterogeneous.

Conclusion

The use of chlorhexidine dressings significantly reduced the incidence of CRBSIs, catheter colonization and CRIs in hospitalized patients. Our results support the use of chlorhexidine dressings in hospitalized patients with indwelling CVCs, which has important implications for CVCs care. Future research should focus on which populations may benefit the most from the use of chlorhexidine dressings, the frequency of chlorhexidine dressing replacement, and the longest indwelling time of CVCs.

Ethical considerations

Ethical issues (Including plagiarism, informed consent, misconduct, data fabrication and/or falsification, double publication and/or submission, redundancy, etc.) have been completely observed by the authors.
  31 in total

1.  Guidelines for the prevention of intravascular catheter-related infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Am J Infect Control       Date:  2011-05       Impact factor: 2.918

2.  Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: results from a prospective randomized controlled trial.

Authors:  S T Chambers; J Sanders; W N Patton; P Ganly; M Birch; J A Crump; R L Spearing
Journal:  J Hosp Infect       Date:  2005-09       Impact factor: 3.926

3.  Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study.

Authors:  Itzhak Levy; Jacob Katz; Ester Solter; Zmira Samra; Bernardo Vidne; Einat Birk; Shai Ashkenazi; Ovadia Dagan
Journal:  Pediatr Infect Dis J       Date:  2005-08       Impact factor: 2.129

4.  Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.

Authors:  Kostoula Arvaniti; Dimitrios Lathyris; Phyllis Clouva-Molyvdas; Anna-Bettina Haidich; Eleni Mouloudi; Eleni Synnefaki; Vasiliki Koulourida; Dimitrios Georgopoulos; Nikoleta Gerogianni; Georgios Nakos; Dimitrios Matamis
Journal:  Crit Care Med       Date:  2012-02       Impact factor: 7.598

5.  Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-03-04       Impact factor: 17.586

6.  A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.

Authors:  J S Garland; C P Alex; C D Mueller; D Otten; C Shivpuri; M C Harris; M Naples; J Pellegrini; R K Buck; T L McAuliffe; D A Goldmann; D G Maki
Journal:  Pediatrics       Date:  2001-06       Impact factor: 7.124

7.  Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability.

Authors:  Marisa A Montecalvo; Donna McKenna; Robert Yarrish; Lynda Mack; George Maguire; Janet Haas; Lawrence DeLorenzo; Norine Dellarocco; Barbara Savatteri; Addie Rosenthal; Anita Watson; Debra Spicehandler; Qiuhu Shi; Paul Visintainer; Gary P Wormser
Journal:  Am J Med       Date:  2012-05       Impact factor: 4.965

Review 8.  The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention.

Authors:  Nasia Safdar; Christopher J Crnich; Dennis G Maki
Journal:  Respir Care       Date:  2005-06       Impact factor: 2.258

9.  Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial.

Authors:  Heiner Ruschulte; Matthias Franke; Petra Gastmeier; Sebastian Zenz; Karl H Mahr; Stefanie Buchholz; Bernd Hertenstein; Hartmut Hecker; Siegfried Piepenbrock
Journal:  Ann Hematol       Date:  2008-08-05       Impact factor: 3.673

10.  Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial.

Authors:  Jean-François Timsit; Carole Schwebel; Lila Bouadma; Arnaud Geffroy; Maïté Garrouste-Orgeas; Sebastian Pease; Marie-Christine Herault; Hakim Haouache; Silvia Calvino-Gunther; Brieuc Gestin; Laurence Armand-Lefevre; Véronique Leflon; Chantal Chaplain; Adel Benali; Adrien Francais; Christophe Adrie; Jean-Ralph Zahar; Marie Thuong; Xavier Arrault; Jacques Croize; Jean-Christophe Lucet
Journal:  JAMA       Date:  2009-03-25       Impact factor: 56.272

View more
  1 in total

Review 1.  [Update of the recommendations of the Bacteraemia Zero Project].

Authors:  E Gallart; M Delicado; X Nuvials
Journal:  Enferm Intensiva       Date:  2022-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.